Structure Therapeutics Inc ADR

GPCRNASDAQ · USD
36.81USD0.00 (0.00%)
2110

Structure Therapeutics Inc ADR (GPCR) Option Chain

As of September 21, 2026, Structure Therapeutics Inc ADR is trading at $36.81, a +0.00% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 63.6%. IV Rank is 3%.

Read more

Tracking the GPCR option chain helps you see every strike and expiry on Structure Therapeutics Inc ADR in one view, so you can quickly identify the contracts that fit your thesis and your risk. Structure Therapeutics Inc ADR's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GPCR options activity at a glance. Use our scanner to monitor the GPCR option chain in real time and filter for the GPCR options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GPCR stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the GPCR option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where GPCR stock options are being actively traded and where they are not.

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF.

The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Structure Therapeutics Inc ADR's full chain across every expiry, highlights the most liquid strikes, and lets you screen GPCR options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of GPCR stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile13.10% Subdued
  • Market cap (M$)2,625
  • 52 weeks high-61.21%
  • 52 weeks low56.04%
  • Analyst recommendationStrong Buy
    1.12
  • Target price$106.73
    189.95% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-3.08
  • EPS growth next 5 years

As of September 21, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
24.64100.594.313.905.9032.50-11.710.351.250.000.8023275.36
40.59412731.161.812.153.8035.00-4.921.052.300.001.681517259.41
57.097062.180.001.253.1037.50+1.871.303.900.691.91011342.91
71.523232961.150.001.001.3040.00+8.673.705.603.191.46220628.48
82.5085121.150.000.551.7542.50+15.465.907.605.691.0602017.50

As of September 21, 2026

Scan the full option chain in one place

Browse the full GPCR option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial